Hans von Celsing

Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA.

NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia.

Trondheim Estate AS provides ultrasound and navigation surgery techniques. Its products include 10 FPA MC, 8 FPA and 12 FLA. The firm develops, manufactures and sells SonoWand Invite 3D ultrasound and neuro-navigation system. The company was founded by Atle Kleven in October 1998 and is headquartered in Trondheim, Norway.

Part of Elekta AB, Elekta Holdings US, Inc. is a company that provides secure software for robust data security and multi-layer threat protection. The company is based in Norcross, GA, and the CEO of the company is James P. Hoey. The company helps clinicians treat cancer and brain disorders through precision radiation medicine, targeting the tumor and protecting the patient. Elekta has been providing innovative technologies to improve cancer care across the globe for 50 years. The company also offers precise and personalized veterinary radiation therapy using linear accelerators for cats, dogs, and other animals.

Mirada Medical Ltd. develops software applications for medical imaging. The firm's software allows images from multiple sources to be combined to provide greater clinical certainty in diagnosis and treatment of cancer. It provides radiology, radiation therapy, tumor board and referring physician solutions. The firm specializes in simplifying technically complex image quantification, allowing clinicians to more confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention. The company was founded by Mark E. Evans in 1999 and is headquartered in Oxford, the United Kingdom.